Nothing Special   »   [go: up one dir, main page]

IL111144A0 - Pharmaceutical compositions containing amiodarone for the treatment of heart failure - Google Patents

Pharmaceutical compositions containing amiodarone for the treatment of heart failure

Info

Publication number
IL111144A0
IL111144A0 IL11114494A IL11114494A IL111144A0 IL 111144 A0 IL111144 A0 IL 111144A0 IL 11114494 A IL11114494 A IL 11114494A IL 11114494 A IL11114494 A IL 11114494A IL 111144 A0 IL111144 A0 IL 111144A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
compositions containing
heart failure
containing amiodarone
Prior art date
Application number
IL11114494A
Original Assignee
Roemmers Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roemmers Sa filed Critical Roemmers Sa
Publication of IL111144A0 publication Critical patent/IL111144A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/556Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11114494A 1993-10-04 1994-10-03 Pharmaceutical compositions containing amiodarone for the treatment of heart failure IL111144A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93116013 1993-10-04

Publications (1)

Publication Number Publication Date
IL111144A0 true IL111144A0 (en) 1994-12-29

Family

ID=8213319

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11114494A IL111144A0 (en) 1993-10-04 1994-10-03 Pharmaceutical compositions containing amiodarone for the treatment of heart failure

Country Status (3)

Country Link
AU (1) AU7854094A (en)
IL (1) IL111144A0 (en)
WO (1) WO1995009625A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243529T1 (en) * 1995-02-10 2003-07-15 Searle & Co COMBINATION OF ACE INHIBITORS WITH ALDOSTERONE ANTAGONISTS FOR THE TREATMENT OF VENTRICULAR HYPERTROPHY
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease
FR2735365B1 (en) * 1995-06-14 1997-09-05 Sanofi Sa USE OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURANE DERIVATIVE FOR THE PREPARATION OF A MEDICAMENT USEFUL IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS
FR2746013B1 (en) * 1996-03-18 1998-05-29 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY
FR2760364A1 (en) * 1997-03-10 1998-09-11 Sanofi Sa USE OF ANTIARRHYTHMIC COMPOUNDS FOR REDUCING MORTALITY AFTER MYOCARDIAL INFARCTION
US6048874A (en) * 1999-01-26 2000-04-11 Medeva Pharmaceuticals Manufacturing, Inc. Parenteral metolazone formulations
CN102423305A (en) * 2011-12-23 2012-04-25 中国药科大学 Isosorbide mononitrate micro-porous osmotic pump tablet and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2626176A1 (en) * 1988-01-25 1989-07-28 Baligadoo Soorianarain Cardioprotective medicinal preparations comprising amiodarone, a nitro derivative and optionally a beta-blocker
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
EP0413694B1 (en) * 1989-02-20 1993-05-12 BALIGADOO, Soorianarain Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker

Also Published As

Publication number Publication date
WO1995009625A1 (en) 1995-04-13
AU7854094A (en) 1995-05-01

Similar Documents

Publication Publication Date Title
IL102571A0 (en) Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
IL88207A0 (en) Imidazole compounds and pharmaceutical compositions for the treatment of osteoporosis
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
AP9300581A0 (en) Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use
IL104409A0 (en) Pharmaceutical compositions containing pyridobenzodiazepinones for axial myopia therapy
AU7812794A (en) Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract
NO934832D0 (en) Pharmaceutical composition for the prevention or treatment of arterioscerosis
GB2162748A (en) Medicinal composition for the treatment or prevention of acne by oral administration
IL105285A0 (en) Compositions for the treatment of diabetes
IL110780A0 (en) Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL102895A0 (en) Pharmaceutical compositions for lowering blood lipid levels
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IL122731A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
IL106961A0 (en) Pharmaceutical compositions for treatment of the eyes
GB9413939D0 (en) Pharmaceutical composition for the treatment of chronic skin ulcers